pharmaceutical distributors
pharmaceutical distributors with http://www.takeyourmeds.info

pharmaceutical distributors

Take Your Meds

News for 22-Jul-20

Source: MedicineNet Kids Health General
Rest May Not Be Best for Kids After Concussion

Source: MedicineNet Kids Health General
Down Syndrome May Not Be Big Financial Burden on Families

Source: MedicineNet Kids Health General
Some Kids' Genes Might Make Food Ads More Tempting

Source: MedicineNet Kids Health General
Teen Violence Can Be Contagious, Study Contends

Source: MedicineNet Kids Health General
Growth Charts

Source: MedicineNet Kids Health General
Health Tip: If Your Child is Cyberbullied

Source: MedicineNet Kids Health General
Baby Crib Ads Show Unsafe Practices, Study Says

Source: MedicineNet Kids Health General
Health Tip: Help Toddlers Develop Stronger Hands

Source: MedicineNet Kids Health General
Child Deaths Highlight Choking Dangers Posed by Grapes

Source: MedicineNet Kids Health General
Teens May Not Heed Health Warnings on Cigars

Search the Web
generic pharmaceutical association
pharmaceutical distributors
www rx com
viagra online
canadian pharmacy
pharma''s
herbal medications
orphan drugs
rosacea resources
wheelchairs

The Best pharmaceutical distributors website

All the pharmaceutical distributors information you need to know about is right here. Presented and researched by http://www.takeyourmeds.info. We've searched the information super highway far and wide to provide you with the best pharmaceutical distributors site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
pharmaceutical distributors.

pharmaceutical distributors
pharmaceutical distributors, , pharmaceutical distributors, , pharmaceutical distributors,
http://www.medmeet.com/
CLICK HERE RIGHT NOW

pharmaceutical distributors
www rx com
viagra online
canadian pharmacy
pharma''s
herbal medications
orphan drugs
rosacea resources
wheelchairs
low cost prescriptions
propecia prescriptions
onlinedoctors
repackagers
geneva pharmaceutical
cheap medicine
american council on pharmaceutical education
psychology
wallsend self help group
exsar
grocery
pharmaceutical representatives
drugs in sports
marketers
recovery
forest pharmaceuticals
viagra buy online
buy viagra
procurement of medical supplies
upjohn''s
ghb
sample online
books
phentermine online pharmacy
mexico drugstore
recruiters
dannex
buying prescriptions from canada
rx success
aerius
glaxo smith kline
canada online pharmacy
perscription drugs
pharmaceutical sales representative
pharmaceutical information
illegal drugs
rite aid
no to drugs
emergency medical supplies
free drugs
pharmaceutical conferences
home care
johnson pharmaceutical
generic pharmaceutical association

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

 by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1104 - 1107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).

Criterion of Therapeutic Effect:

  1. If HBV-DNA volume 1104 cp/mL: 4/25 (16%)

  2. Lasting response:

HBV-DNA volume 1104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1102 cp/mL). The testing range of this testing method is 1102 - 1107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com


5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314

About The Author

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Google

http://www.medmeet.com/
Broadcast On the Net | Medical Meetings | Medical Meetings On The Net | Take Medicine Correctly | Internet Meetings

Medical Meetings On The Net   RX Right!   Take It Correctly